The expertise of Hyun-Il Cho ranks in the
- Top 2.2%
- ... of 107,286 published authors worldwide on Melanoma
- ... from 2008 through 2019
- ... based on contributions to
9 articles
on the topic.
Graphical view (beta)
Hide
Longer horizontal black lines means more people have that level of expertise.
Expertise level forHyun-Il Cho |
|
|
|
|
Higher
Amount of
expertise
(logarithmic)
Lower
|
|
Uncounted papers?
|
| Most likely: |
|
|
Catholic University of Korea |
|
|
|
| 2016 | - Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Pubmed 27323820
- Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. Electronic address: · Pubmed 26828454
|
|
| Probable: |
|
|
University of South Florida |
Contact |
|
|
| 2013 | - Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; Department of Medicine, Massachusetts General Hospital, Boston, MA. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; Massachusetts Institute of Technology, Cambridge, MA. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; University of Cincinnati, 2600 Clifton Ave, Cincinnati, OH 45221. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; Janssen Research and Development, division of Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse B2340, Belgium. · Dept. of Immunology, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612. · Pubmed 24459675
- Immunology Program, Moffitt Cancer Center, Tampa, FL 33612, USA. · Pubmed 23266830
|
| 2012 | - Immunology Program, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA. · Pubmed 22367213
- Cancer Vaccine Group, Immunology Program, Moffitt Cancer Center, 12902 Magnolia Drive, SRB2, Tampa, FL 33612, USA. · Pubmed 21915800
|
| 2011 | - Immunology Program, Moffitt Cancer Center, Tampa, FL 33612, USA. · Pubmed 20889921
|
| 2009 | - Immunology Program, Moffitt Cancer Center, and Department of Oncologic Sciences, University of South Florida, Tampa, Florida, USA. · Pubmed 19903852
|
| 2008 | - Department of Immunology, Moffitt Cancer Center, Tampa, Florida 33612, USA. · Pubmed 19047170
|
|
|
|
In the titles of their published articles, experts often reveal their very specific interests.
Here
are the titles of all articles written by Hyun-Il Cho in 2008-2019
about Melanoma:
- Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy. 2016
- Zoledronic acid induces dose-dependent increase of antigen-specific CD8 T-cell responses in combination with peptide/poly-IC vaccine. 2016
- Transnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activity. 2013
- BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses. 2013
- A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapy. 2012
- Design of immunogenic and effective multi-epitope DNA vaccines for melanoma. 2012
- Interferon γ limits the effectiveness of melanoma peptide vaccines. 2011
- Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects. 2009
- In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells. 2008
Show List of Full Article Records
|
|
Learn more about Hyun-Il Cho using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!
| General Search: |
|
| Catholic University of Korea |
|
|
| University of South Florida |
|
|
|
|
Click for institutional directory in table below. (Not always available.)
What is this?
|
|
|
|
Catholic University of Korea
|
| | |
|
| 2016 | - Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Pubmed 27323820
- Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. · Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea. Electronic address: · Pubmed 26828454
|
|
|
|
|
University of South Florida
|
| | |
|
| 2013 | - Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; Department of Medicine, Massachusetts General Hospital, Boston, MA. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; Massachusetts Institute of Technology, Cambridge, MA. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; University of Cincinnati, 2600 Clifton Ave, Cincinnati, OH 45221. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142 ; Janssen Research and Development, division of Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse B2340, Belgium. · Dept. of Immunology, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612. · Pubmed 24459675
- Immunology Program, Moffitt Cancer Center, Tampa, FL 33612, USA. · Pubmed 23266830
|
| 2012 | - Immunology Program, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA. · Pubmed 22367213
- Cancer Vaccine Group, Immunology Program, Moffitt Cancer Center, 12902 Magnolia Drive, SRB2, Tampa, FL 33612, USA. · Pubmed 21915800
|
| 2011 | - Immunology Program, Moffitt Cancer Center, Tampa, FL 33612, USA. · Pubmed 20889921
|
| 2009 | - Immunology Program, Moffitt Cancer Center, and Department of Oncologic Sciences, University of South Florida, Tampa, Florida, USA. · Pubmed 19903852
|
| 2008 | - Department of Immunology, Moffitt Cancer Center, Tampa, Florida 33612, USA. · Pubmed 19047170
|
|
|
| Yearly article counts |
0 | 0 | 0 | 2 | 0 | 0 | 2 | 2 | 1 | 0 | 1 | 1 |
|
|
You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape
"Saved Pages" page, which is always easily available
from the page-top menu bar throughout the site.
|
